Please assess the completion status of the following clinical trial:

Trial Title: Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* type 2 diabetes mellitus~* age \>=20 years~* spot urine albumin/creatinine ratio \> 30mg/g in two consecutive measurements~* patients on ACE-inhibitor or ARB as an anti-hypertensive drug~* blood pressure \<= 150/100 mmHg~* HbA1c \<10%~Exclusion Criteria:~* taking insulin pentoxifylline, cilostazol, ketas, viagra in 3 months~* ischemic heart disease, stroke, malignant disease, severe infection in 6 months~* serum creatinine \> 2.0mg/dl~* severe liver disease or AST, ALT \> 3\* ULM~* taking systemic steroid in 1 month~* pregnant or plan to become pregnant during the clinical trial~* lactation

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Pentoxifylline (Type: ACTIVE_COMPARATOR): Pentoxifylline 400mg three times a day
- Placebo (Type: PLACEBO_COMPARATOR): placebo tablet

Based on this trial design, predict the completion outcome and termination type (if applicable).